Researchers identified a protective, age-dependent role for the enzyme nicotinamide N-methyltransferase (NNMT) in vascular endothelium, according to findings published November 12, 2026, in Circulation Research.
The study, conducted by teams from the Beijing Hospital and other institutions including the Chinese Academy of Medical Sciences, suggests that NNMT maintains vascular health by regulating an endothelial stress-response axis involving the protein lamin A/C (LMNA).
The research team, which included contributors such as Mingjun Wang, Miao Wang, and colleagues across the National Center of Gerontology and the Fuwai Hospital, observed that NNMT expression declines in both senescent human umbilical vein endothelial cells and in a small, pathological, male-only cohort of older versus younger plaque-adjacent human carotid intimal donors. This decline was further mirrored in primary mouse aortic endothelial cells.
Mechanistically, the study indicates that NNMT influences the maintenance of the LMNA promoter by reducing histone H3 lysine 27 trimethylation occupancy. This stabilization works in conjunction with the activation and nuclear translocation of heat shock transcription factor 1 (HSF1), which subsequently drives the transcription of heat shock proteins HSP90 and HSP70. Exploratory multiomics integration, including transcriptomic analyses and Cleavage Under Targets and Tagmentation, provided these insights into the NNMT-associated stress-response axis.
Separately, research published November 19, 2026, in the journal SLEEP examined different mechanisms of vascular dysfunction. This work was conducted by a team including Rene Cortese, Kylie Cataldo, Mohammad Badran, Milda Milciute, Juozas Gordevicius, Zhuanhong Qiao, Jonathan Eusey, Abdelnaby Khalyfa, and David Gozal.
Beijing Hospital, a Class-A tertiary institution under the National Health Commission, maintains a significant reputation for its specialized expertise in gerontological research, training, and patient care. This clinical focus aligns with its collaborative academic efforts, such as the recent vascular health study conducted alongside the Chinese Academy of Medical Sciences.
The institutional relationship between these two entities is rooted in a history of administrative coordination, as Beijing Hospital was previously placed under the leadership of the Chinese Academy of Medical Sciences in December 1958. This legacy of cooperation continues to support the hospital’s role as a major research hub, leveraging its long-standing experience to contribute to national medical advancements alongside leading academic partners.
While the study in Circulation Research focuses on the metabolic-epigenetic integration provided by NNMT to protect against vascular aging, the SLEEP study highlights distinct pathways contributing to stress-induced endothelial impairment. Neither study provides medical advice for human patients.
Readers should consult with qualified healthcare professionals regarding vascular health, as clinical applications of these findings—such as S-adenosylmethionine supplementation or the use of compounds like Heterophyllin B—remain in the stage of experimental research.